• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    FDA Issues Form 483 to Hikma Injectables USA

    FDA

    Enforcement Report - Week of March 12, 2025

    FDA

    Enforcement Report - Week of January 15, 2025

    FDA

    Enforcement Report - Week of January 8, 2025

    FDA

    FDA Issues Form 483 to Hikma Injectables USA

    FDA

    Hikma Pharmaceuticals Issues Voluntary Nationwide Recall for Acetaminophen Injection

    FDA

    FDA Issues Form 483 to Hikma Pharmaceuticals USA

    FDA

    Enforcement Report - Week of May 29, 2024

    FDA

    Enforcement Report - Week of March 27, 2024

    FDA

    Enforcement Report - Week of May 24, 2023

    FDA

    Enforcement Report - Week of January 4, 2023

    FDA

    Class 2 Medicines Recall: Hikma Pharmaceuticals USA Inc, Lorazepam

    GOVUK

    Enforcement Report - Week of September 1, 2021

    FDA

    Enforcement Report - Week of September 2, 2020

    FDA

    Enforcement Report - Week of June 24, 2020

    FDA

    Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine

    FDA

    Enforcement Report - Week of January 29, 2020

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.